Takahiro Tsukimura

Plasma globotriaosylsphingosine as a biomarker of Fabry disease

Tadayasu Togawa, Takashi Kodama, Toshihiro Suzuki et al. · Molecular Genetics and Metabolism · 2010 · 143 citations

Medicine, Biochemistry, Molecular Medicine +6

Plasma lyso-Gb3: a biomarker for monitoring fabry patients during enzyme replacement therapy

Hitoshi Sakuraba, Tadayasu Togawa, Takahiro Tsukimura et al. · Clinical and Experimental Nephrology · 2017 · 90 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Structural and biochemical studies on Pompe disease and a “pseudodeficiency of acid α-glucosidase”

Youichi Tajima, Fumiko Matsuzawa, Sei-ichi Aikawa et al. · Journal of Human Genetics · 2007 · 54 citations

Life Sciences, Biochemistry, Molecular Biology +7

Use of a Modified α-N-Acetylgalactosaminidase in the Development of Enzyme Replacement Therapy for Fabry Disease

Youichi Tajima, Ikuo Kawashima, Takahiro Tsukimura et al. · The American Journal of Human Genetics · 2009 · 53 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +13

Molecular Basis of 1-Deoxygalactonojirimycin Arylthiourea Binding to Human α-Galactosidase A: Pharmacological Chaperoning Efficacy on Fabry Disease Mutants

Yi Yu, Teresa Mena‐Barragán, Katsumi Higaki et al. · ACS Chemical Biology · 2014 · 52 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17